Dry eye syndrome is characterized by the eye’s inability to remain lubricated. The problem usually occurs as the tear film fails to produce and maintain good-quality tears. The condition causes irritation, burning, and a sensation of something in the eyes. Dry eye can be caused by factors that limit tear production, while others increase tear evaporation.
MEIBOMIAN GLAND DYSFUNCTION
Meibomian gland dysfunction (MGD) occurs when the function of the glands is disrupted, negatively affecting the quality and quantity of tears. The glands secrete meibum that helps provide tear film stability.
Changes in tear film composition affect the ocular surface due to increased evaporation and hyperosmolarity. Ocular surface damage and inflammation can cause extreme discomfort and visual problems.
RISK FACTORS FOR MGD
Some individuals have a higher risk of developing MGD. Risk factors include:
- Hormonal aspects
- Systemic medications
- Topical medications
- Poor diet
- Ocular surface microbiome
- Contact lens wear
- Congenital problems
OPTILIGHT BY LUMENIS® FOR MGD
OptiLight™ is a noninvasive, light-based treatment that helps manage dry eye. The FDA-approved treatment is applied along the meibomian glands, helping manage the symptoms of dry eye.
The safe and effective therapy uses light pulses to reduce inflammation associated with dry eye. It improves tear breakup time, increasing meibomian gland function. It can significantly relieve indicators of dry eye.
HOW OPTILIGHT WORKS
OptiLight works in various ways to relieve dry eye symptoms for people with MGD or evaporative dry eye. It functions using specific light wavelengths by:
- Increasing tear breakup time (TBUT)
- Eliminating blood vessels that cause inflammation
- Reducing bacteria and Demodex mites around the eyes
- Improving the function of the meibomian gland
DURING OPTILIGHT THERAPY
OptiLight treatment is simple, fast, and painless. During the procedure, the doctor will cover the eyes using shields and apply the gel to the treatment site. The coupling gel is ideal even for sensitive skin and is easy to clean off afterward. The light is applied to the skin, producing a bright flash and warm sensation.
The treatment takes 10 to 15 minutes and is gentle, with minimal discomfort. After treatment, sunscreen is applied to the area. Meibomian gland expression is performed to improve the treatment effectiveness.
POOR CANDIDATES FOR OPTILIGHT
While it is an effective treatment for most, OptiLight is not for everyone. Individuals with aqueous deficiency and dry eye are not good candidates. Poor candidates are those prone to keloid scarring and those with severe scarring around the eyes. The eye doctor will examine your condition to evaluate if you are a good candidate for the therapy.
For two weeks after OptiLight, you should wear sunscreen around the treated area daily. You will likely experience skin flushes in the area, but this is normal. Placing a cold compress over the area can help reduce redness and soothe the area.
Avoid using harsh cleaners or lid scrubs, but you can return to your cleaning routine soon after treatment. Contact an eye specialist to find out if OptiLight can benefit your eye condition.
For more on using OptiLight to measure the impact of glandular dysfunction on vision, visit Lansdowne Eye Associates at our office in Lansdowne, Pennsylvania. Call (610) 623-1127 to book an appointment today.